March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Learn how to care for yourself as you get tips about being ready to go back to work, what kind of work you want to do, and applying for jobs.
Read about the symptoms, diagnosis, and treatment of different fungal infections, including candidiasis, cryptococcus, histoplasmosis, and more.
Learn about a variety of treatments for fat gain, or lipohypertrophy.